Opportunity Information: Apply for PAR 23 300
The Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) is a discretionary grant opportunity from the National Institutes of Health (NIH) aimed at strengthening research administration capacity at research institutions located in low- and middle-income countries (LMICs). Listed under Funding Opportunity Number PAR-23-300, this program focuses on building practical, senior-level administrative expertise so that LMIC institutions can more effectively manage NIH awards, meet compliance expectations, and maintain strong stewardship of U.S. federal research funds, particularly for awards supported by the National Institute of Allergy and Infectious Diseases (NIAID). The overall intent is not to fund clinical trials, but to develop institutional capability and professionalism in grants management and oversight.
At its core, the program is designed to provide advanced training for senior administrators at LMIC research institutions. That means the emphasis is on strengthening the people and systems responsible for administering NIH grants, including the policies, procedures, and internal controls that ensure funds are used appropriately and projects are managed in line with NIH requirements. The notice highlights improving oversight of NIAID grant awards and ensuring compliance with NIH funding policies and broader U.S. federal research funding rules that apply to foreign institutions receiving NIH support. In practice, this often includes areas like pre-award and post-award grants management, budgeting and financial oversight, documentation and recordkeeping, reporting requirements, subaward management, procurement standards, audit readiness, and institutional governance structures that support accountability and compliance.
Eligibility is geared toward non-U.S. entities, specifically foreign (non-domestic) organizations, with the stated target being research institutions in LMICs. The opportunity is categorized as a grant (Funding Instrument Type: Grant) within the health funding activity category and is associated with CFDA number 93.855. Because the goal is to improve the quality of administration and compliance for NIH-funded activities, the strongest applications are typically those that can clearly describe existing administrative gaps, identify the senior staff who will receive advanced training, and outline a structured plan for how that training will translate into lasting institutional improvements. While the NOFO summary does not list required components in detail, the purpose statement suggests that NIH expects an approach that goes beyond one-off workshops and instead results in measurable improvements in institutional capacity to manage NIH grants responsibly.
The award has a stated ceiling of $100,000. The listing does not specify the number of expected awards in the provided source data, but it indicates that the program is active with an original closing date of March 13, 2026. The opportunity was created on September 11, 2023. Importantly, the designation "Clinical Trial Not Allowed" means applicants should not propose clinical trials as part of the project activities; the work should remain focused on research administration development and grants management training rather than conducting clinical research interventions. Overall, this funding opportunity is best understood as a capacity-building mechanism: it supports LMIC institutions in developing stronger grants administration leadership and systems so that NIAID and NIH-funded projects are managed with high standards of compliance, transparency, and effectiveness.Apply for PAR 23 300
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
- This funding opportunity was created on 2023-09-11.
- Applicants must submit their applications by 2026-03-13. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled the Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed).
What is the Funding Opportunity Number (NOFO) for this program?
The Funding Opportunity Number is PAR-23-300.
Which agency is offering this grant?
This is a discretionary grant opportunity from the National Institutes of Health (NIH).
What is the main purpose of this award?
The purpose is to strengthen research administration capacity at research institutions located in low- and middle-income countries (LMICs). The focus is on building practical, senior-level administrative expertise so institutions can more effectively manage NIH awards, meet compliance expectations, and maintain strong stewardship of U.S. federal research funds, particularly for awards supported by the National Institute of Allergy and Infectious Diseases (NIAID).
Is this award intended to fund research projects or institutional capacity building?
Based on the opportunity description provided, it is best understood as a capacity-building mechanism. It supports development of institutional capability and professionalism in grants management and oversight rather than funding clinical research interventions.
Are clinical trials allowed under this opportunity?
No. The program is designated "Clinical Trial Not Allowed," meaning applicants should not propose clinical trials as part of the project activities.
If clinical trials are not allowed, what kinds of activities are this grant meant to support?
The emphasis is on advanced training and development for senior administrators and on strengthening the people and systems responsible for administering NIH grants. The description highlights improvements in administrative expertise, policies, procedures, and internal controls related to responsible management of NIH-funded awards.
What areas of research administration does the opportunity aim to strengthen?
The opportunity description points to strengthening oversight and compliance for NIH-funded activities, including areas such as pre-award and post-award grants management, budgeting and financial oversight, documentation and recordkeeping, reporting requirements, subaward management, procurement standards, audit readiness, and governance structures that support accountability and compliance.
Who is the intended audience for the training supported by this award?
The program is designed to provide advanced training for senior administrators at LMIC research institutions, with an emphasis on senior-level administrative expertise and practical capacity that improves institutional grants management.
What types of organizations are eligible to apply?
Eligibility is geared toward non-U.S. entities, specifically foreign (non-domestic) organizations, with the stated target being research institutions in low- and middle-income countries (LMICs).
Is this opportunity limited to institutions working on infectious diseases?
The opportunity is positioned within global infectious disease research administration development and emphasizes improving oversight of NIAID-supported awards. The central focus described is research administration capacity for NIH/NIAID grant stewardship and compliance.
Which NIH institute is particularly emphasized in this opportunity?
The description specifically highlights improving oversight of grant awards supported by the National Institute of Allergy and Infectious Diseases (NIAID).
What does it mean that the grant focuses on stewardship of U.S. federal research funds?
It means the program is aimed at helping LMIC institutions manage NIH awards responsibly and in line with NIH requirements and broader U.S. federal research funding rules that apply to foreign institutions receiving NIH support. The goal is strong compliance, transparency, and effective oversight of awarded funds.
What is the funding instrument type for this opportunity?
The funding instrument type is a Grant.
What is the activity category associated with this opportunity?
It is listed within the health funding activity category.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.855.
What is the maximum award amount (ceiling) listed for this opportunity?
The stated award ceiling is $100,000.
How many awards does NIH expect to make under this opportunity?
The provided information does not specify the expected number of awards.
When is the application closing date?
The listing indicates an original closing date of March 13, 2026.
When was this opportunity created?
The opportunity was created on September 11, 2023.
What would likely make an application stronger based on the purpose statement?
The description suggests strong applications will clearly describe existing administrative gaps, identify the senior staff who will receive advanced training, and present a structured plan showing how training will translate into lasting institutional improvements. The emphasis appears to be on measurable improvements rather than one-off workshops.
Does the opportunity description require a particular program design (for example, workshops vs. longer-term plans)?
While the summary does not list required components in detail, it indicates NIH expects an approach that goes beyond one-time workshops and results in measurable, lasting improvements in institutional capacity to manage NIH grants responsibly.
What kinds of institutional improvements are implied by "capacity development" in this program?
Implied improvements include stronger grants management leadership, clearer or improved policies and procedures, better internal controls, more reliable documentation and reporting practices, improved financial oversight, and overall greater readiness to meet NIH and U.S. federal compliance expectations for foreign recipients of NIH funding.
What is the overall intent of this funding opportunity in one sentence?
To help LMIC research institutions build senior-level research administration and compliance capacity so NIH (especially NIAID) awards are managed effectively, transparently, and in accordance with NIH and U.S. federal requirements, without supporting clinical trials.
Browse more opportunities from the same category: Health
Next opportunity: Single Source for continuation of the Human Pancreas Analysis Program for Type-2 Diabetes (HPAP-T2D) (U01 Clinical Trial Not Allowed)
Previous opportunity: Locally Led Development for USAID/Nepal’s Local Works Addendum
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 300
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 300) also looked into and applied for these:
| Funding Opportunity |
|---|
| Computational Models of Influenza Immunity (U01 Clinical Trial Not Allowed) Apply for RFA AI 23 056 Funding Number: RFA AI 23 056 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 017 Funding Number: RFA RM 23 017 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Program (HVP) (U24 Clinical Trial Not Allowed) Apply for RFA RM 23 016 Funding Number: RFA RM 23 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,875,000 |
| Human Virome Characterization Centers (U54 Clinical Trial Not Allowed) Apply for RFA RM 23 019 Funding Number: RFA RM 23 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed) Apply for RFA RM 23 018 Funding Number: RFA RM 23 018 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Computationally-Defined Behaviors in Psychiatry (R21 Clinical Trial Optional) Apply for PAR 23 305 Funding Number: PAR 23 305 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Computational Approaches for Validating Dimensional Constructs of Relevance to Psychopathology (R01 Clinical Trial Optional) Apply for PAR 23 307 Funding Number: PAR 23 307 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 332 Funding Number: RFA MH 24 332 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required) Apply for RFA MD 24 003 Funding Number: RFA MD 24 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) Apply for PAR 23 301 Funding Number: PAR 23 301 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) Apply for PAR 23 302 Funding Number: PAR 23 302 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed) Apply for RFA AI 23 054 Funding Number: RFA AI 23 054 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) Apply for RFA DE 24 006 Funding Number: RFA DE 24 006 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed) Apply for PAR 23 221 Funding Number: PAR 23 221 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Apply for PAR 24 037 Funding Number: PAR 24 037 Agency: National Institutes of Health Category: Health Funding Amount: $2,500,000 |
| National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32) Apply for PAR 23 228 Funding Number: PAR 23 228 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Development and Renovation of Facilities for Expanding the Breeding Capacity of Specific Pathogen Free Non-Human Primates to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed) Apply for PAR 24 033 Funding Number: PAR 24 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 23 306 Funding Number: PAR 23 306 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (U19 Clinical Trial Not Allowed) Apply for RFA AI 23 057 Funding Number: RFA AI 23 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA EB 23 006 Funding Number: RFA EB 23 006 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 300", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.